Careers

Our people are our most important asset

As a rapidly growing, award-winning biotechnology company, we are always looking for talented individuals to join our team.

Retrogenix is a thriving small biotech which serves a global market from its main laboratory facilities near Manchester in the UK and a US office in Cambridge, MA. Our unique cell microarray technology fills a previously unmet need in the global biopharmaceutical, drug discovery and academic market for identifying the receptors, drug targets and off-targets of biological molecules (e.g. antibodies, soluble proteins, viruses). The technology platform been presented at international scientific conferences and our results have led to publications in leading scientific journals, including Nature, Molecular Cancer, Cancer Cell and Oncotarget.

Our current vacancies and details of how to apply are below.

View Opportunities

Current Opportunities

to join the Retrogenix Team
Scientist (Biology), UK – 3 posts available

As a result of a rapidly increasing number of projects and collaborations with pharmaceutical companies and academic partners, Retrogenix has exciting opportunities for several talented and organized biologists to join its growing team...

US Business Development Sales Executive

**This position is now closed**

Working for Retrogenix
Our dedicated team is at the cutting edge, providing breakthrough results for global pharmaceutical companies, top biotechs and leading academics.
Pfizer
The University of Sheffield
Aveo Oncology - The Human Response
Theraclone Sciences
BioInvent
AstraZeneca
Bluebird Bio
The Center for Infectious Disease Research
Compugen Logo
The University of Copenhagen
Lund University
MedImmune
NIH - National Institutes of Health
The University of Pennsylvania
Scripps Florida - The Scripps Research Institute
Peptinnovate Ltd - Unlocking Nature's Potential
We are very happy with our collaboration with Retrogenix, and how their platform has delivered.
Dr. Björn Frendéus, Vice President of Pre-clinical Research at BioInvent International A/B